HealthDay on MSN
Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results